Dr. Ahmed Selim, MD, MS
What this data tells you about Dr. Selim
Dr. Ahmed Selim is a cardiovascular disease in Burleson, TX, with 15 years in practice. Based on federal Medicare data, Dr. Selim performed 1,396 Medicare services across 944 unique beneficiaries.
Between the years covered by Open Payments, Dr. Selim received a total of $123,287 from 16 pharmaceutical and/or device companies across 207 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Selim is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity | 195 | $91 | $223 |
| Office visit, established patient (30-39 min) | 128 | $91 | $232 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 117 | $29 | $75 |
| Initial hospital admission, high complexity | 112 | $135 | $434 |
| Remote pacemaker/defibrillator monitoring, 90 days | 111 | $18 | $66 |
| Electrocardiogram (EKG), 12-lead | 106 | $11 | $42 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 90 | $20 | $56 |
| Remote pacemaker monitoring, 90 days | 71 | $23 | $74 |
| Office visit, established patient, complex (40-54 min) | 55 | $126 | $310 |
| New patient office visit (45-59 min) | 41 | $117 | $355 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 40 | $29 | $146 |
| Office visit, established patient (20-29 min) | 38 | $65 | $156 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 31 | $699 | $1,761 |
| New patient office visit, complex (60-74 min) | 30 | $154 | $442 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 25 | $20 | $75 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 25 | $663 | $900 |
| Ultrasound of heart with probe in esophagus, with report | 22 | $83 | $237 |
| Ultrasound of heart blood flow, valves and chambers | 22 | $14 | $42 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 22 | $2 | $30 |
| Programming of heart rhythm stimulation after drug infusion | 21 | $62 | $250 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 19 | $226 | $660 |
| Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | 18 | $24 | $60 |
| Echocardiogram, transthoracic | 16 | $140 | $471 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 14 | $197 | $320 |
| Hospital follow-up visit, moderate complexity | 14 | $62 | $155 |
| External shock to heart to regulate heart beat | 13 | $84 | $535 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (83%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work. Total industry engagement is in the top 5% for cardiovascular disease in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Selim is a remote & electrophysiology specialist, with moderate Medicare volume, and high industry engagement (research-focused, top 5%), with 15 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Selim experienced with hospital follow-up visit, high complexity?
Does Dr. Selim receive payments from pharmaceutical companies?
How do Dr. Selim's costs compare to other cardiovascular diseases in Burleson?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology